Q2 2026 13F · SEC CIK 1166309
Bridger Management, LLC
Hedge fundFiled 2026-08-18 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $150.1M
- Reported positions
- 24
- Top holdings a year, 3 yrs
- +16.2%
- Assets under management
- $485.2M
Bridger Management, LLC is a hedge fund that reported 24 positions worth $150.1M in its Q2 2026 13F, filed 2026-08-18. Its largest holdings were Morgan Stanley (MS, 15.6%), Amazon Com Inc (AMZN, 10.0%), Teva Pharmaceutical Inds Ltd (TEVA, 8.3%). A portfolio copying its top holdings returned 16.2% a year over the last 3 years, against 22.3% for the S&P 500.
Bridger Management, LLC holdings all 24 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| MSMorgan Stanley | 15.6% | +0.0% | $23.5M |
| AMZNAmazon Com Inc | 10.0% | +0.0% | $15.0M |
| TEVATeva Pharmaceutical Inds Ltd | 8.3% | +0.0% | $12.5M |
| UNHUnitedhealth Group Inc | 6.6% | — | $9.9M |
| FLUTFlutter Entmt PLC | 6.3% | +0.0% | $9.4M |
| LLYEli Lilly & Co | 4.7% | +23.4% | $7.0M |
| DXCMDexcom Inc | 4.6% | +0.0% | $6.9M |
| GOOGLAlphabet Inc | 4.4% | +0.0% | $6.6M |
| MLMMartin Marietta Matls Inc | 4.2% | +44.7% | $6.4M |
| VVisa Inc | 3.9% | +0.0% | $5.9M |
| MSGKMadison Square Grdn Sprt Corp Cl A | 3.5% | +0.0% | $5.3M |
| CHDNChurchill Downs Inc | 3.4% | +0.0% | $5.1M |
| OSCROscar Health, Inc. | 3.3% | — | $4.9M |
| HQYHealthequity Inc | 3.1% | — | $4.7M |
| MSFTMicrosoft Corp | 3.1% | +0.0% | $4.6M |
| DASHDoordash Inc | 2.9% | +0.0% | $4.4M |
| UBERUber Technologies Inc | 2.8% | +0.0% | $4.2M |
| HIMSHims & Hers Health Inc | 2.8% | — | $4.2M |
| IBITIshares Bitcoin Trust ETF | 1.8% | +0.0% | $2.8M |
| MLCOMelco Resorts and Entmnt Ltd | 1.8% | +0.0% | $2.8M |
| SPCXSpace Exploration Techn Corp | 1.8% | — | $2.6M |
| TOSTToast Inc | 0.7% | +0.0% | $1.1M |
| NEXTNextdecade Corp | 0.3% | +0.0% | $511K |
| SRZNWSurrozen Inc | 0.0% | +0.0% | $7K |
What Bridger Management, LLC bought and sold in Q2 2026, against Q1 2026.
New positions
- UNH Unitedhealth Group Inc6.6% of 13F
- OSCR Oscar Health, Inc.3.3% of 13F
- HQY Healthequity Inc3.1% of 13F
- HIMS Hims & Hers Health Inc2.8% of 13F
- SPCX Space Exploration Techn Corp1.8% of 13F
Added to
- MLM Martin Marietta Matls Inc+44.7% shares
- LLY Eli Lilly & Co+23.4% shares
Reduced
No position shrank by more than 5%.
Sold out
- ALC Alcon Incwas 5.0%
- NKE Nike Incwas 5.0%
- AORT Artivion Incwas 3.8%
- BBNX Beta Bionics Incwas 1.3%
- RXST Rxsight Incwas 1.2%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +5.0% /yr
- S&P 500 +11.7%
- 3 years
- +16.2% /yr
- S&P 500 +22.3%
- 5 years
- +3.7% /yr
- S&P 500 +10.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $150.1M | 24 |
| Q1 2026 | $128.0M | 24 |
| Q4 2025 | $155.5M | 24 |
| Q3 2025 | $185.6M | 28 |
| Q2 2025 | $169.6M | 25 |
| Q1 2025 | $201.2M | 29 |
| Q4 2024 | $186.1M | 28 |
| Q3 2024 | $199.9M | 29 |
| Q2 2024 | $194.3M | 28 |
| Q1 2024 | $221.8M | 31 |
| Q4 2023 | $259.5M | 28 |
| Q3 2023 | $271.9M | 31 |
Questions about Bridger Management, LLC's portfolio
What stocks does Bridger Management, LLC own?
Bridger Management, LLC's latest 13F, for Q2 2026 and filed Aug 18, 2026, lists 24 positions worth $150.1M. The largest are Morgan Stanley (MS) at 15.6%, Amazon Com Inc (AMZN) at 10.0%, Teva Pharmaceutical Inds Ltd (TEVA) at 8.3%, Unitedhealth Group Inc (UNH) at 6.6% and Flutter Entmt PLC (FLUT) at 6.3%.
What did Bridger Management, LLC buy last quarter?
In Q2 2026, Bridger Management, LLC added a new position in Unitedhealth Group Inc (UNH), a new position in Oscar Health, Inc. (OSCR), a new position in Healthequity Inc (HQY), a new position in Hims & Hers Health Inc (HIMS), a new position in Space Exploration Techn Corp (SPCX), Martin Marietta Matls Inc (MLM) (+44.7% shares) and Eli Lilly & Co (LLY) (+23.4% shares), compared with its Q1 2026 filing.
What did Bridger Management, LLC sell last quarter?
In Q2 2026, Bridger Management, LLC sold all of Alcon Inc (ALC), sold all of Nike Inc (NKE), sold all of Artivion Inc (AORT), sold all of Beta Bionics Inc (BBNX) and sold all of Rxsight Inc (RXST), compared with its Q1 2026 filing.
How has Bridger Management, LLC's portfolio performed?
A portfolio copying Bridger Management, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +16.2% a year over the last 3 years, against +22.3% for the S&P 500. Over 1 year: +5.0% against +11.7%. Over 5 years: +3.7% a year against +10.6%.
When is Bridger Management, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Bridger Management, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Bridger Management, LLC manage?
Bridger Management, LLC reported $485.2M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $150.1M.